These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30715304)

  • 1. Recombinant activated factor VII in neonatal cardiac surgery.
    Christoff AS; Winlaw DS; Curtin J; Barnes EH; Egan JR
    Eur J Cardiothorac Surg; 2019 May; 55(5):817-822. PubMed ID: 30715304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Factor VIIa in Pediatric Cardiac Surgery.
    Morrison S; Lacey C; Attard C; Davies B; Monagle P; Davies P
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):684-689. PubMed ID: 34479781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
    Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
    Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Mini-Volume Priming During Cardiopulmonary Bypass on Clinical Outcomes in Low-Bodyweight Neonates: Less Transfusion and Postoperative Extracorporeal Membrane Oxygenation Support.
    Kim SY; Cho S; Choi E; Kim WH
    Artif Organs; 2016 Jan; 40(1):73-9. PubMed ID: 26642833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
    Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
    Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery.
    Emani S; Zurakowski D; Baird CW; Pigula FA; Trenor C; Emani SM
    Ann Thorac Surg; 2013 Aug; 96(2):651-6. PubMed ID: 23809731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports.
    Leighton BL; Wall MH; Lockhart EM; Phillips LE; Zatta AJ
    Anesthesiology; 2011 Dec; 115(6):1201-8. PubMed ID: 21720243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
    Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
    [No Abstract]   [Full Text] [Related]  

  • 12. Association Between Cyanosis, Transfusion, and Thrombotic Complications in Neonates and Children Undergoing Cardiac Surgery.
    Ali U; Goldenberg N; Foreman C; Crawford Lynn L; Honjo O; O'Leary J; Faraoni D
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):349-355. PubMed ID: 31399304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
    Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Allen NN; Wilson EC; Foster GS; Ehrlich AC; Miller BE
    Anesth Analg; 2015 Feb; 120(2):405-10. PubMed ID: 25390280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal insufficiency in neonates after cardiac surgery with cardiopulmonary bypass.
    Crawford JH; Hull MS; Borasino S; Steenwyk BL; Hock KM; Wall K; Alten JA
    Paediatr Anaesth; 2017 Jan; 27(1):77-84. PubMed ID: 27779350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
    Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
    Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant activated factor VII for refractory bleeding post complex cardiothoracic surgery.
    Walsham J; Fraser JF; Mullany D; Ziegenfus M; Chinthamuneedi M; Dunning J; Tesar P
    Anaesth Intensive Care; 2006 Feb; 34(1):13-20. PubMed ID: 16494143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.